ArticlePoultry science2026
Molecular characterization and pathogenicity of H9N2 avian influenza viruses in poultry in Shandong Province, China, 2021-2023.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The H9N2 avian influenza virus (AIV) is currently widespread worldwide, posing a severe threat to the poultry industry and public health. To investigate the epidemiological characteristics, genomic evolution, and mammalian pathogenicity of poultry-derived H9N2 viruses in Shandong Province, a total of 192 samples from diseased chickens were collected across 10 cities in Shandong Province between February 2021 and December 2023. Real-time quantitative PCR (RT-qPCR) detection identified 10 positive samples, from which 8 virus strains were isolated. Five representative isolates were selected for whole-genome sequencing, phylogenetic analysis, molecular characterization, and mouse pathogenicity evaluation. Infected chickens mainly showed respiratory symptoms and pathological lesions in multiple organs. The five isolates shared 91.3%-99.8% nucleotide identity and were highly homologous (98.26%-99.95%) with recent Chinese H9N2 strains. Phylogenetic results indicated multiple-lineage reassortment: PB2 and M genes belonged to the G1-like lineage, PB1, PA, NP, and NS genes to the SH/F98-like lineage, and HA and NA genes to the Y280-like lineage. All isolates carried the low‑pathogenic HA cleavage site (PSRSSR/GL) and human adapted receptor binding mutations (HA Q226L, I163T, H183N), with HA glycosylation loss at position 218 but retention at 313. In addition, substitutions were observed at antigenic sites, including G90E, S145D, N167G, and T200R. All isolates carried mammalian adaptation related mutations, such as PB2 A588V, PA K356R, PA-X R195K and NS1 F103L/M106I; only the CK/SD/TA1016/22 strain contained the PB2 K526R mutation. All strains carried M2 S31N conferring amantadine resistance, and a new NA glycosylation site at position 306 was found in CK/SD/TA803/22. The pathogenicity to mice showed that the three tested isolates could replicate efficiently in the lungs without prior adaptation, but could not cause mice death. Among them, the CK/SD/TA1016/22 strain showed higher replication levels and more severe lung lesions. In conclusion, H9N2 AIV in Shandong Province continue to evolve and undergo antigenic drift, and they possess evident potential for mammalian adaptation. Continuous epidemiological surveillance and risk assessment are therefore strongly recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.